智通财经APP讯，大健康国际(02211)发布公告，于2025年5月13日，本公司(作为发行人)与认购人皇御控股订立认购协议，认购人已有条件同意认购而本公司已有条件同意以现金约2435万港元配发及发行合共3.04亿股现有股份或3044.03万股合并股份(视情况而定)，认购价为每股现有股份0.08港元或每股合并股份0.80港元(视情况而定)。
假设本公司的已发行股本于本公告日期至交割日期止期间内并无变动，认购协议项下的股份相当于本公告日期本公司现有已发行股本约38.00%;及本公司经配发及发行认购协议项下认购股份扩大后的已发行股本约27.54%。
认购价每股现有股份0.08港元较2025年5月13日(即认购协议日期)于联交所所报每股现有股份收市价0.081港元折让约1.23%;及为股份于紧接认购协议日期前五个连续交易日于联交所所报平均收市价每股现有股份0.0778港元溢价约2.83%。
假设认购股份获悉数认购，预期认购事项的所得款项总额将约为2435万港元。认购事项所得款项净额亦约为2435万港元，相当于每股认购股份净价约0.08港元或0.80港元(视情况而定)。本公司拟将所得款项净额用作本集团一般营运资金。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.